#cancerresearch
Moderna Cancer Vaccine Hits Major Phase 3 Melanoma Milestone
Moderna and Merck announced positive late-stage melanoma trial results on Wednesday, August 19. The Phase 3 study involved 1,137 patients with surgically removed high-risk stage IIB to IV melanoma. Moderna Cancer Vaccine meets key Phase 3 melanoma goals Moderna and Merck have reported a major clinical milestone for their personalised mRNA cancer therapy after the Phase 3 INTerpath-001 trial met its primary and key secondary endpoints in patien
Moderna Cancer Vaccine Hits Major Phase 3 Melanoma Milestone
Moderna and Merck announced positive late-stage melanoma trial results on Wednesday, August 19. The Phase 3 study involved 1,137 patients with surgically removed high-risk stage IIB to IV melanoma. Moderna Cancer Vaccine meets key Phase 3 melanoma goals Moderna and Merck have reported a major clinical milestone for their personalised mRNA cancer therapy after the Phase 3 INTerpath-001 trial met its primary and key secondary endpoints in patien
Shri Nandamuri Balakrishna Opens ISDE India Edition 2026, Celebrates 25 Years of BIACH&RI
On April 10, 2026, Shri Nandamuri Balakrishna inaugurated the ISDE India Edition 2026 conference on esophageal cancer in Hyderabad. This historic event, hosted by the International Society for Diseases of the Esophagus (ISDE) in collaboration with Basavatarakam Indo-American Cancer Hospital & Research Institute (BIACH&RI), marked the first time the conference was held in India. The event also commemorated BIACH&RI’s Silver Jubilee, celebrating 25 years of dedication to cancer ca
Shri Nandamuri Balakrishna Opens ISDE India Edition 2026, Celebrates 25 Years of BIACH&RI
On April 10, 2026, Shri Nandamuri Balakrishna inaugurated the ISDE India Edition 2026 conference on esophageal cancer in Hyderabad. This historic event, hosted by the International Society for Diseases of the Esophagus (ISDE) in collaboration with Basavatarakam Indo-American Cancer Hospital & Research Institute (BIACH&RI), marked the first time the conference was held in India. The event also commemorated BIACH&RI’s Silver Jubilee, celebrating 25 years of dedication to cancer ca









